FBXL18 and hepatocellular carcinoma: Univariate and multivariate analyses revealed that FBXL18 expression (p = 0.048), histological grade (p = 0.037), and recurrence (p = 0.013) were negatively associated with OS in HCC patients, indicating that FBXL18 is an independent risk factor in HCC patients (OS, [HR]: 0.5276; 95% [Cl]: 0.2797–0.9953; p = 0.048, Table 2).